Annals of Oncology - Google Scholar-Kennzahlen

h5-Index:122
h5-Median:196

Der h5-Index ist der h-Index für Artikel, die in den letzten fünf Jahren veröffentlicht wurden. Dieser Index bedeutet, dass in den Jahren 2014-2018 h Publikationen jeweils mindestens h-mal zitiert wurden.Ausblenden

Der h5-Median einer Publikation ist der Median der Zitierhäufigkeit der Artikel, auf denen der h5-Index der Publikation basiert.Ausblenden

#7 Oncology

Titel/Autor	Zitiert von	Jahr
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of Oncology 26 (8), 1533-1546	1064	2015
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of Oncology 26 (suppl_5), v8-v30	830	2015
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ... Annals of Oncology 27 (8), 1386-1422	815	2016
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of Oncology 26 (2), 259-271	796	2014
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Van Cutsem, A Cervantes, B Nordlinger, D Arnold Annals of Oncology 25 (suppl_3), iii1-iii9	639	2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ... Annals of Oncology 25 (8), 1544-1550	621	2014
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies J Naidoo, DB Page, BT Li, LC Connell, K Schindler, ME Lacouture, ... Annals of Oncology 26 (12), 2375-2391	580	2015
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F André, CH Barrios, ... Annals of Oncology 25 (10), 1871-1888	565	2014
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Reck, S Popat, N Reinmuth, D De Ruysscher, KM Kerr, S Peters Annals of Oncology 25 (suppl_3), iii27-iii39	539	2014
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up S Novello, F Barlesi, R Califano, T Cufer, S Ekman, MG Levra, K Kerr, ... Annals of Oncology 27 (suppl_5), v1-v27	532	2016
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ... Annals of Oncology 26 (8), 1547-1573	476	2015
Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies DSM Chan, AR Vieira, D Aune, EV Bandera, DC Greenwood, ... Annals of Oncology 25 (10), 1901-1914	466	2014
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up B Eichhorst, T Robak, E Montserrat, P Ghia, P Hillmen, M Hallek, C Buske Annals of Oncology 26 (suppl_5), v78-v84	416	2015
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ... Annals of Oncology 28 (1), 16-33	391	2017
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up H Tilly, M Gomes da Silva, U Vitolo, A Jack, M Meignan, ... Annals of Oncology 26 (suppl_5), v116-v125	388	2015
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Ducreux, C Caramella, A Hollebecque, P Burtin, D Goéré, T Seufferlein, ... Annals of Oncology 26 (suppl_5), v56-v68	383	2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, ... Annals of Oncology 27 (1), 16-41	373	2015
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up J Haanen, F Carbonnel, C Robert, KM Kerr, S Peters, J Larkin, K Jordan Annals of Oncology 28 (suppl_4), iv119-iv142	367	2017
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer K Azuma, K Ota, A Kawahara, S Hattori, E Iwama, T Harada, K Matsumoto, ... Annals of Oncology 25 (10), 1935-1940	365	2014
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of Oncology 25 (suppl_3), iii102-iii112	352	2014

1 - 20

Datumsangaben und Zitierhäufigkeiten werden automatisch von einem Computerprogramm ermittelt und stellen Schätzwerte dar.